Advertisement
Research Article| Volume 28, ISSUE 7, P629-637, October 01, 1990

Elevated CSF protein in male patients with depression

  • Andrew F. Pitts
    Affiliations
    From the Department of Psychiatry University of Iowa College of Medicine, Iowa City, Iowa, USA

    Neuroscience Program, University of Iowa College of Medicine, Iowa City, Iowa, USA
    Search for articles by this author
  • Brendan T. Carroll
    Affiliations
    From the Department of Psychiatry University of Iowa College of Medicine, Iowa City, Iowa, USA
    Search for articles by this author
  • Timothy L. Gehris
    Affiliations
    From the Department of Psychiatry University of Iowa College of Medicine, Iowa City, Iowa, USA
    Search for articles by this author
  • Roger G. Kathol
    Correspondence
    Address reprint requests to Roger G. Kathol, M.D., Departments of Psychiatry and Internal Medicine, University of Iowa Hospitals, 500 Newton Road, Iowa City, IA 52242.
    Affiliations
    From the Department of Psychiatry University of Iowa College of Medicine, Iowa City, Iowa, USA

    From the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa, USA
    Search for articles by this author
  • Stephen D. Samuelson
    Affiliations
    From the Department of Psychiatry University of Iowa College of Medicine, Iowa City, Iowa, USA

    Neuroscience Program, University of Iowa College of Medicine, Iowa City, Iowa, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Elevation of total protein is the most frequent pathologic finding in the cerebrospinal fluid (CSF) examination. It occurs in a variety of situations such as inflammation or tumors of the central nervous system (CNS), degenerative disorders, and subarachnoid hemorrhage, or as a result of traumatic taps. It has also been reported, for unknown reasons, in patients with psychiatric disease. In a study of hormone changes in depression, 9 of 24 (38%) patients (13 male, 11 female) were found to have elevated CSF protein levels (>45 mg/dl), whereas no elevations were found in healthy controls (8 male, 9 female). Eight of the patients with the elevated CSF protein levels were male (62%) and one was female (9%). Depressed patients had significantly higher CSF protein levels (44.7 ± 18.0 mg/dl) than controls (31.5 ± 6.0 mg/dl) (t = 3.32, df = 30.37, p = 0.002). No relationship was found between CSF protein levels and (1) the use of medication (tricyclic antidepressants, lithium carbonate, or monoamine oxidase inhibitors) or (2) post-dexamethasone suppression test cortisol levels. Female controls, however, tended to have lower protein levels than male controls, whereas female patients had significantly lower levels than male patients. Protein electrophoresis was performed on 21 of the 41 subjects (13 patients, 8 controls). Male patients had nonsignificantly higher absolute concentrations of CSF albumin and the globulin fractions when compared to male controls. These differences in CSF protein do not suggest monoclonal CSF protein production, nor are they the result of this elevated peripheral protein. They suggest increased polyclonal production of CSF protein and/or increased blood-brain barrier permeability in male depressed patients, and a tendency to such in female depressed patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        3rd ed. rev. American Psychiatric Press, Washington, DC1987
        • Bradford M.M.
        A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
        Anal Biochem. 1976; 72: 248-254
        • Bellak L.
        Dementia Praecox.
        in: Grune & Stratton, New York1948: 105
        • Breutsch W.L.
        The schizophrenic patients with an increase of the protein content of the cerebrospinal fluid.
        Am J Psychiatry. 1958; 115: 545
        • Breutsch W.L.
        • Bahr M.A.
        • Skobba J.S.
        • Dieter W.J.
        The group of dementia praecox patients with an increase of protein content of the cerebrospinal fluid.
        J Nerv Ment Dis. 1942; 95: 669-679
        • Caroscio J.T.
        • Kochwa S.
        • Sacks H.
        • Cohen J.A.
        • Yahr M.D.
        Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases: An update.
        Arch Neurol. 1983; 40: 409-413
        • Dencker S.J.
        • Zethraeus S.
        Sex differences in total protein content of cerebrospinal fluid.
        Acta Psychiatr Scand. 1961; 36: 76-82
        • Denzel H.A.
        Spinal fluid changes in patients treated with ataractic drugs.
        Am J Psychiatry. 1960; 116: 545
        • Dougherty J.M.
        • Roth R.M.
        Cerebral spinal fluid.
        Emerg Med Clin North Am. 1986; 4: 281-296
        • Epstein E.
        • Zak B.
        • Baginski E.S.
        • Civin W.H.
        Interpretation of cerebrospinal fluid proteins by gel electrophoresis.
        Ann Clin Lab Sci. 1976; 6: 27-37
        • Epstein E.
        Quantitative fractional protein determination in the cerebrospinal fluid according to Lehmann's modification of the Biuret method.
        Acta Psychiatr Neurol. 1947; 22: 211-239
        • Fishman R.A.
        Cerebrospinal Fluid in Disease of the Central Nervous System.
        Saunders, Philadelphia1980 (chap 6)
        • Glasser L.
        Body fluids III: Tapping the wealth of information in CSF.
        Diagn Med. 1981; (Jan/Feb): 23-33
        • Hamilton M.
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Haug J.O.
        Pneumoencephalographic studies in mental disease.
        Acta Psychiat Scand. 1962; 38: 96-101
        • Hoerster S.A.
        • Hillman F.A.
        • Bohls S.W.
        • Lara F.Y.
        • Thurman N.
        Cerebrospinal fluid in mental disease (a study using paper electrophoresis).
        Dis Nerv Syst. 1963; 24: 357-360
        • Hunter R.
        • Jones M.
        • Malleson A.
        • Duncan C.
        Abnormal cerebrospinal fluid total protein and gamma-globulin levels in 256 patients admitted to a psychiatric unit.
        J Neurol Sci. 1969; 9: 11-38
        • Killingsworth L.M.
        • Cooney S.K.
        • Tyllia M.M.
        • Killingsworth C.E.
        Deciphering cerebrospinal fluid patterns.
        Diagn Med. 1980; (Mar/Apr): 23-29
        • Lopez J.F.
        • Kathol R.G.
        • Jaeckle R.S.
        • Meller W.
        The HPA response to insulin hypoglycemia in depression.
        Biol Psychiatry. 1987; 22: 133-167
        • Marton K.I.
        • Gean A.D.
        The spinal tap: A new look at an old test.
        Ann Intern Med. 1986; 104: 840-848
        • Simpson G.M.
        • Cooper T.M.
        The effect of phenothiazines on cerebrospinal fluid.
        Int J Neuropsychiatry. 1966; 2: 223-226
        • Smith J.K.
        Spinal fluid changes during chlorpromazine therapy.
        Am J Psychiatry. 1958; 115: 167
        • Soffer L.J.
        • Iannaccone A.
        • Gabrilove J.L.
        Cushing's syndrome. A study of fifty patients.
        Am J Med. 1961; 30: 129-146
        • Solomon P.
        • Schwab R.S.
        • Malitz L.
        A follow-up study of non-luetic psychotic patients with abnormalities in the spinal fluid.
        Am J Psychiatry. 1940; 96: 1035-1041
        • Spitzer R.I.
        • Endicott J.
        Schedule for Affective Disorders and Schizophrenia—Lifetime Version.
        Biometric Research, New York State Psychiatric Institute, New York1978
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research diagnostic criteria. Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Tourcellotte W.W.
        • Shorr R.J.
        Cerebrospinal fluid.
        in: Youmans J.P. Neurosurgery. Saunders, Philadelphia1982
        • Trethowan W.H.
        • Cobb S.
        Neuropsychiatric aspects of Cushing's syndrome.
        Arch Neurol Psychiatry. 1952; 67: 283-309
        • von Delank H.W.
        Der Liquor cerebrospinalis bei den sogenannten Hirnatrophien.
        Fortschr Neurol Psychiatr. 1957; 25: 355-364